Condition

Pancreatic Adenosquamous Carcinoma clinical trials and research

• 5Clinical trials
• 18Countries

Newest Pancreatic Adenosquamous Carcinoma clinical trials

All recruiting trials (5)

• Zoldonrasib plus Daraxonrasib vs Gemcitabine and Nab-Paclitaxel as first-line treatment for metastatic KRAS G12D pancreatic cancer

  This study tests whether two investigational RAS inhibitors together can improve outcomes compared with standard chemotherapy in adults with newly diagnosed metastatic pancreatic cancer carrying the KRAS G12D mutation.

  Recruiting at 6 sites Phase 3 Revolution Medicines, Inc. · Phoenix, Arizona and 5 other locations · NCT07805954

• Zoldonrasib + chemotherapy vs placebo + chemotherapy as first-line treatment for metastatic KRAS G12D pancreatic cancer

  This trial tests whether adding zoldonrasib to standard chemotherapy helps people with newly diagnosed metastatic KRAS G12D pancreatic cancer.

  Recruiting at 25 sites Phase 3 Revolution Medicines, Inc. · Phoenix, Arizona and 24 other locations · NCT07621718

• Daraxonrasib alone or with gemcitabine and nab-paclitaxel for first-line metastatic pancreatic cancer

  This trial will see if daraxonrasib, alone or with gemcitabine and nab-paclitaxel, helps people with newly diagnosed metastatic pancreatic cancer live longer or slow tumor growth compared with standard gemcitabine and nab-paclitaxel.

  Recruiting at 61 sites Phase 3 Revolution Medicines, Inc. · Phoenix, Arizona and 81 other locations · NCT07491445

• Using Olaparib to Prevent Recurrence in Patients with Resected Pancreatic Cancer and Specific Genetic Mutations

  This study is testing if the drug olaparib can help prevent pancreatic cancer from coming back in patients who have had surgery and specific genetic mutations.

  Recruiting at 261 sites Phase 2 National Cancer Institute (NCI) · Anchorage, Alaska and 455 other locations · NCT04858334

• Dendritic cell therapy combined with chemotherapy for pancreatic cancer

  This study is testing a new treatment that combines a special type of immune cell therapy with chemotherapy to see if it helps people with pancreatic cancer after surgery.

  Recruiting at 3 sites Phase 1 Diakonos Oncology Corporation · Houston, Texas and 2 other locations · NCT04157127

Related topics

Quick answers

How many Pancreatic Adenosquamous Carcinoma clinical trials are recruiting right now?

5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 18 countries. The most sites are in United States (5 trials), Austria (2 trials), Italy (2 trials), Netherlands (2 trials), United Kingdom (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 3, Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →